Ibrance 125 MG capsule 21S
Ended Awarded
- Contract number
- SPE2DB25FSGDY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,236
Award facts
- Contract value 100% obligated
- $16,236.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,236.16 to AmerisourceBergen Drug Corp for the supply of Ibrance 125 mg capsules (21-count) on September 29, 2025, with an ultimate completion date of October 21, 2025. This is a firm fixed-price contract with no set-aside designation, indicating competitive award. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products to military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor specializing in military and veteran healthcare supply. Ibrance (palbociclib) is an oncology medication used in breast cancer treatment, reflecting the breadth of specialized pharmaceutical commodities the company delivers through its DLA contract portfolio. The award demonstrates AmerisourceBergen's continued capability to meet federal procurement requirements in open competition. The DLA Troop Support Medical contract enables the company to serve multiple federal customers including the Defense Health Agency and U.S. Coast Guard, supporting military healthcare systems globally through flexible delivery order mechanisms.
Quick answers
Who was awarded contract SPE2DB25FSGDY?
SPE2DB25FSGDY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 29, 2025.
How much is contract SPE2DB25FSGDY worth?
The government has obligated $16,236 on SPE2DB25FSGDY.
Is contract SPE2DB25FSGDY an order under another contract?
Yes. SPE2DB25FSGDY is a delivery order under SPE2DB22D2211, an indefinite delivery contract.
Was contract SPE2DB25FSGDY competed?
The extent of competition for SPE2DB25FSGDY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award